<SEC-DOCUMENT>0001571049-16-015200.txt : 20160512
<SEC-HEADER>0001571049-16-015200.hdr.sgml : 20160512
<ACCEPTANCE-DATETIME>20160512161520
ACCESSION NUMBER:		0001571049-16-015200
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160512
DATE AS OF CHANGE:		20160512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		161643865

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1600319_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 16pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>Applied DNA
Sciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction<BR>
        of incorporation)</P></TD>
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>001-36745</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices; zip
code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&#8217;s telephone number, including
area code:<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom:Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&#160; </TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 2.02&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On May 12, 2016, Applied DNA Sciences, Inc. (&#8220;Applied DNA
Sciences&#8221; or the &#8220;Company&#8221;) issued a press release announcing its results of operations for the fiscal quarter
ended March 31, 2016. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The information furnished pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly
set forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Press Release of Applied DNA Sciences, Inc. dated May 12, 2016 regarding results of operations for the fiscal quarter ended March 31, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>





<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom:Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&#160; </TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: May 12, 2016</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%"></TD>
    <TD STYLE="width: 6%"></TD>
    <TD STYLE="width: 43%"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom:Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&#160; </TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%"></TD>
    <TD STYLE="width: 89%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated May 12, 2016 regarding results of operations for the fiscal quarter ended March 31, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&#160; </TD></TR></TABLE></DIV>
    <!-- Field: /Page -->





<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>t1600319_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="logo1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Sciences Reports Fiscal Second
Quarter 2016 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Company to Hold Conference
Call and Webcast Today at 4:30 PM Eastern Time</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>STONY BROOK, NY. May 12, 2016 </B>&ndash; Applied DNA Sciences,
Inc. (NASDAQ: APDN) (Twitter: @APDN) (Applied DNA) (the Company), a provider of DNA-based supply chain, anti-counterfeiting and
anti-theft technology, product genotyping and product authentication solutions, announced financial results for the fiscal 2016
second quarter ended March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Our second quarter results reflect variability in the
timing of purchase orders and contract awards. While revenue was lower than we planned, we continued to advance initiatives across
our revenue-generating verticals to further entrench our anti-counterfeiting and authentication solutions with customers,&rdquo;
stated Dr. James A. Hayward, chairman and CEO of Applied DNA. &ldquo;We on-boarded six new cotton manufacturers, began offering
DNAnet Home Asset Marking kits through the Automobile Association of America (AAA) website, increased the annual commitment of
DNAnet used to protect luxury brands of European automobiles, and, subsequent to the close of the quarter, were awarded up to a
$2.5 million follow-on Blanket Purchase Agreement (BPA) from a U.S. government agency.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Second Quarter Financial Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Revenues decreased 62% for the second quarter of fiscal 2016 to $573 thousand, compared with $1.5 million reported in the second
quarter of fiscal 2015, and decreased 57% from the $1.3 million reported in the first fiscal quarter ended December 31, 2015.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The year-over-year decrease in revenue is primarily attributable to the scheduled lower revenue from two government contract
awards and a decrease in revenue from suppliers of the Defense Logistics Agency (DLA) due to the consolidation of our contracts
with multiple individual suppliers of the DLA to one contract directly with DLA, as well as a decrease in revenue from another
Federal Agency. The sequential decrease in revenues resulted primarily from lower revenue from the two government contract awards,
a decrease in revenue in DNA manufacturing for the diagnostic market as well as decrease in revenue for textiles related to DNA
transfer units that were installed during the prior fiscal quarter.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Total operating expenses for the second quarter of fiscal 2016 were $4.0 million, compared with $3.4 million in the prior year&rsquo;s
quarter, an increase of approximately $623 thousand or 18%. The increase in year-over-year total operating expenses is primarily
attributable to an increase in selling, general and administrative expense, research and development expense and depreciation and
amortization expenses. Total operating expense for the fiscal second quarter of 2016 decreased $224 thousand as compared to total
operating expenses of $4.2 million in the fiscal first quarter of 2016. The sequential decrease is related to a decrease in selling,
general and administrative expense of $434 thousand and depreciation and amortization expense of $47 thousand, offset by an increase
in research and development expenses of $257 thousand.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Net loss for the quarter ended March 31, 2016 was $3.5 million, or $0.14 per share, compared with a net loss of $1.9 million,
or $0.11 per share for the quarter ended March 31, 2015 and a net loss of $2.9 million, or $0.13 per share for the quarter ended
December 31, 2015.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Excluding non-cash expenses, Adjusted EBITDA for the quarter ended March 31, 2016 was negative $2.8 million compared to a negative
Adjusted EBITDA of $1.2 million for the same quarter last year and a negative Adjusted EBITDA of $2.2 million in the prior fiscal
quarter reflecting lower revenue. See below for information regarding non-GAAP measures.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Cash and cash equivalents as of March 31, 2016 totaled $9.8 million as compared to $12.4 million at December 31, 2015. The
decrease in cash balances is due primarily to the use of cash to fund operations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Net cash used in operating activities in the fiscal second quarter of 2016 was $2.5 million. This compares with $1.6 million
for the corresponding prior-year period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">First Six-Month Financial Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The Company recorded six-month revenues of almost $1.9 million, a decrease of 31% from the same period last fiscal year.
                                                                                                                                The decrease in revenues was from a scheduled decrease in revenue related from the two government contract awards of
                                                                                                                                $478,000, which expire in July and August of 2016, and a decrease in revenue from suppliers of the DLA due to the
                                                                                                                                consolidation of our contracts with several individual suppliers of the DLA to one contract directly with the DLA as well as
                                                                                                                                other decreases in revenue from another military customer for a total decrease of approximately $410,000. These decreases
                                                                                                                                were offset by an increase in revenue in  DNA manufacturing for the diagnostic market of $242 thousand.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Operating expenses for the six months ended March 31, 2016 decreased by approximately $189 thousand or 2% for the same period
last fiscal year. The decrease is primarily attributable to a decrease in stock-based compensation expense associated with grants
to employees during the six month period ended March 31, 2015, offset by an increase in research and development expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Net loss for the six months ended March 31, 2016 was $6.4 million or $0.27 per share, compared with a net loss of $9.7 million
or $0.59 per share for the six months ended March 31, 2015.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Excluding non-cash expenses and interest Adjusted EBITDA for the six months ended March 31, 2016 would have been a negative
$5.0 million compared with an Adjusted EBITDA of negative $2.9 million for the same period last year. See below for information
regarding non-GAAP measures.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commenting on the Company&rsquo;s business outlook for the second
half of 2016, Dr. Hayward stated, &ldquo;Although we believe we have substantial near-term opportunities in our pipeline, predicting
their timing and size is an ongoing challenge. In cotton, revenue visibility through our partners is limited even as awareness
and interest by brands and retailers build in the PimaCott&trade; and HomeGrown&trade; cotton brands. We are seeing interest by
diverse retailers that would indicate revenue growth relative to last year, but until demand converts into firm purchase orders,
we are unable to predict with certainty our growth. What is clear is that we are filling a real need in the marketplace, and I
am pleased to report that PimaCott cotton is now available on the shelves of a second major North American retailer, and that apparel
customers are just beginning to authenticate their cotton label compliance with our DNA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Progress is rarely linear and this is especially true
for early-stage growth companies like Applied DNA,&rdquo; concluded Dr. Hayward. &ldquo;Demand for our solutions is burgeoning
and we are nurturing that demand with our technology and our people to assure our future success.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On February 25, Applied DNA introduced new pharmaceutical-grade and packaging inks suitable for tablet and packaging marking
in partnership with Nissha Printing Company and Kishu Giken Kogyo Co., Ltd. This partnership offers solutions for Japanese pharmaceutical
manufacturers to comply with a July 2016 regulatory deadline to ensure product integrity and protect patient safety by barcoding
packaging.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         March 2, the Company launched <U>www.dnasecurity.net</U>. Created in conjunction with
                                         Security Marketing Resource (SMR), the website features information and training videos
                                         on Applied DNA&rsquo;s products for security professionals, law enforcement, commercial
                                         organizations and community members, and serves as a conduit to sales of the Company&rsquo;s
                                         DNAnet kits.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On March 3, Applied DNA announced that the U.S. Patent and Trademark Office granted U.S. Patent No. 9,266,370, entitled, &ldquo;DNA
Marking of Previously Undistinguished Items for Traceability&rdquo; to the Company on February 23, 2016. The intellectual property
protected by this patent is applicable in a broad range of markets, including, pharmaceuticals, consumer products, industrial materials,
and electronics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On March 8, the Company announced the on-boarding of six new cotton manufacturers for Pimacott and Homegrown consumer goods.
Since that announcement, additional offshore textile manufacturers have been on-boarded. The addition of these new manufacturers
is expected to expand the Company&rsquo;s footprint in the retail marketplace from 10 SKUs to 1,000, and from 500 stores in the
U.S. Canada and Mexico to 1,700.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On March 21, Applied DNA announced a marketing partnership with AAA to prominently feature the Company&rsquo;s DNAnet kits
to the AAA East Central region&rsquo;s 2.7 million members via its website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On April 4, the Company introduced a proprietary enhanced DNA authentication technology to specifically quantify cotton species.
With this technology, consumer cotton brands can now determine the amounts of inappropriate blends in their cotton and not just
the presence of inferior blends. This technology, combined with the outcome of our United States Department of Agriculture collaboration,
will benefit those retailers who have pledged to avoid products that take advantage of child labor or unethical labor practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On May 1, Applied DNA announced the appointment of former Strategic Advisory Board member Bob Miglani to the new position of
Chief of Business Development to spearhead the Company&rsquo;s penetration of FDA-regulated markets, including pharmaceuticals,
food, personal care and medical devices. Mr. Miglani was most recently with Pfizer Inc. as Senior Director, External Medical Affairs,
where he led Pfizer&rsquo;s efforts to partner with external medical, scientific and consumer organizations. Mr. Miglani has a
proven record of accomplishment of developing innovative partnerships with medical and healthcare organizations in the United States,
Europe, India and other parts of the world.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>On May 10, the Company announced a $2.5 million blanket purchase agreement (BPA) with an undisclosed non-defense Federal agency.
This latest win builds on Applied DNA&rsquo;s current roster of contracts across six defense and non-defense agencies, and represents
a ten-fold increase in this agency&rsquo;s initial work with Applied DNA. The BPA also allows Applied DNA to develop new products
and solutions for the contracting agency at an accelerated deployment pace compared with traditional contract-development paths.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal 2016 Second Quarter Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company will hold a conference call and webcast to discuss
its fiscal 2016 second-quarter results on Thursday, May 12, 2016 at 4:30 PM ET. To participate on the conference call, please follow
the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of the call,
due to the large number of expected participants, not all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To Participate: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reserve your conference call seat now at: http://dpregister.com/10084950.
Conference call dial-in information will be provided at completion of the registration process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Live webcast: http://services.choruscall.com/links/apdn160512</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Replay (available 1 hour following the conclusion of the
live call): </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> Participant
Toll Free: 1-877-344-7529</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> Participant
Toll: 1-412-317-0088</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> Participant
Passcode: 10084950</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> Webcast replay:
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>http://services.choruscall.com/links/apdn160512</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For those investors unable to attend the live call, a copy of
the presentation is expected to be posted by end of business on May 12, 2016 and available under the &ldquo;Investor Information&rdquo;
tab of the company&rsquo;s web site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222"><IMG SRC="logo2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">We
make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting,
fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure
authenticity, traceability and quality of products. SigNature<SUP>&reg;</SUP> DNA describes the platform ingredient that is at
the heart of a family of uncopyable, security and authentication solutions such as SigNature<SUP>&reg;</SUP> T and fiberTyping<SUP>&reg;</SUP>,
targeted toward textiles and apparel, DNAnet<SUP>&reg;</SUP>, for anti-theft and loss prevention, and digitalDNA<SUP>&reg;</SUP>,
providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are
also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Go to <B>adnas.com </B>for more information, events and to learn
more about how Applied DNA Sciences makes life real and safe.&nbsp;Common stock listed on NASDAQ under the symbol APDN, and warrants
are listed under the symbol APDNW.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The statements made by APDN in this press release may be &quot;forward-looking&quot;
in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time
to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and&nbsp;our subsequent
quarterly report on Form 10-Q filed on February 10, 2016 which are available at <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.sec.gov.
</FONT>APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances
after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor contact: </B>&nbsp;Debbie Bailey<B>, </B>631-240-8817<B>,
debbie.bailey@adnas.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.08in">Sanjay Hurry, LHA 212-838-3777,<B>shurry@lhai.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>media contact: </B>Susan Forman, Dian Griesel Int&rsquo;l.<B>,
</B>212-825-3210<B>, sforman@dgicomm.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>web:&nbsp;</B>www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>APPLIED DNA
SCIENCES, INC.<BR>
CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">March&nbsp;31,<BR> 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">September&nbsp;30,&nbsp;<BR> 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(unaudited)</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 74%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">9,785,827</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">7,312,184</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable, net of allowance of $19,453 and $7,140 at March 31, 2016 and September 30, 2015, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,026,854</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,929,517</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">126,367</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">293,351</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,939,048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,535,052</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property, plant and equipment, net of accumulated depreciation of $1,038,674 at March 31, 2016 and $852,867 at September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">879,169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">572,107</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Long term accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,488</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net of accumulated amortization and impairment of $353,816 and $238,368 at March 31, 2016 and September 30, 2015, respectively</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,549,493</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,598,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,711,584</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,554,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,633,774</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,385,006</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">50,162</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">282,050</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,683,936</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,667,056</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Long term accounts payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">320,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,683,936</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,987,456</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Stockholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2016 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Series A Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2016 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Series B Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2016 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Common stock, par value $0.001 per share; 500,000,000 shares authorized; 24,075,092 and 21,504,578 shares issued and outstanding as of March 31, 2016 and September 30, 2015, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,076</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,505</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233,038,874</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">224,186,760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(218,035,302</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(211,641,409</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15,027,648</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,566,856</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,711,584</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,554,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B><BR>
<B>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B><BR>
<B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center">Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center">Six&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 48%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">573,322</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1,518,761</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1,897,436</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2,760,563</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,120,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,901,207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,674,831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,569,950</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">729,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">373,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,201,013</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">651,652</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">170,981</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">123,079</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">389,327</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">232,805</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,020,529</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,397,666</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,265,171</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,454,407</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LOSS FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,447,207</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,878,905</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,367,735</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,693,844</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Interest income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,062</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,907</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,859</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other (expense) income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,478</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,693</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,065</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,135</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(980,842</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Loss on change in fair value of warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,994,540</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,467,623</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,885,582</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,393,893</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,714,220</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,467,623</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,885,582</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(6,393,893</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(9,714,220</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.27</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.59</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average shares outstanding-</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,072,092</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,362,573</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">23,307,134</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,404,299</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B><BR>
<B>CALCULATION AND RECONCILIATION OF ADJUSTED EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center">Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center">Six&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 48%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(3,467,623</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(1,885,582</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(6,393,893</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(9,714,220</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Interest (income) expense, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,062</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,907</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,859</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">123,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">389,327</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">232,805</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Loss on change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,994,540</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">499,668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">539,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">954,781</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,538,519</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">980,842</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">22,313</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">676,587</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">663,059</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,359,514</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,781,344</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,791,036</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,222,523</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,034,379</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,932,876</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="background-color: white">&ndash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *0$, P$1  (1 0,1 ?_$ +4  0 " 04! 0$
M       '"0@!! 4&"@,""P$!  ,  P$!              $&!P,$!0(($
M!@(! P(#! 8%#0     ! @,$!08'"  1$@DA$S$4%4$B%@I183)2(S-Q<A<8
M.)&AL<%"LR0T=;9W2!D1  $"!0,"! 0#! 8+      $  A$#! 4&(3$240=!
M83(3<8$B%)$5%J&Q0C/!T>%BE592<H+2(R0T9#87"/_:  P# 0 "$0,1 #\
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MIBG)=@Q-4XS(F5JY2+)-4''LC.-X)M;;6QBW#B @7TFHJF$:UEI$B:1E3&(
M ;]HO7J!%T?4Z_9RR9KUB^][*8MBL+YPL5>,^R#C&$F23L;5)4L@\00;-Y C
MJ0#HZCDD5SHF<+G;&4%,RAQ*(\(L@FC]H_*91DY;/$2'.F99HY1<I%5(( =(
MQT3G JA>OJ ]!#A%JX?-&AT".G+=L9RJ"#8KAPD@9RL(=020*J<HK*#^Z7J;
M]7"+==?0/3X_YO3A%\4W*"JJB*:J1U4>GNID53.HGU$0#W"%,)D^HAZ=?CPB
M^:;YFLY79I.VRKIL4IG#9-PDHY0*?IVF6;D,*J13=?03  #PB^3^6C(M,BTG
M(,8U%54J*2T@[;LDE5CAU(DFHY43*=0W0>A0ZB/3X<(H<V3S_0]7<"Y/V'R0
MY73H^*ZA(VV8*P BSZ2*W3*E&P\60W5):1G95PW:-NX0)[JY1,(%ZCPB_GEY
MAV6VG\QN=$[/GB<RU0]5H*RN"L:EA_'-HR95L;1Z0 X;1D15XA2.CKEDMPR.
MG[\G)N">R8X& $T/;2&[8=V^NV8\W6^HHJ8AV]75LE,/P!A ?'957+<UM6&2
MV?>_=5'-H/&DI'S9@CK G6)!Z:+G<Z^/S72#.SMFF>1=XH6V07RCZ*@LRZOV
MAHL$TP(DH20@<C4!TS?P+H[Q,5$O<C%/8,(?QN@=0O3NP^4!Q;^9XR8'<7&7
M#Y:[*GM[V8P6-<+5=G$@1+Z&8'?/SZ^:E'#GE0\T.L44M Y"JF0]C<7)LU&L
MS!9YQ5<+@FK"^R9!XW_M%B(V,N3-+Y81 3O'3DJ8=!$OIS-\AQ&\8[4F75.D
MO#'$%TIP>QT#"+'CU-.[7>(U5XLF763(6M-&U['N /%P+7-C_"YI])&Q!V.B
MMPU/_,Q:81=/3JN7<!9,P'+QZBICMZ"9OE*FO'ZYB \42>/WL):(KM%,H DZ
M;*^V0H%!3H'*[2TQKZO[0S&4\QY]3SQ!\]BO9KC,HJ=]5*E/J@T^EFI'DK+:
MKYS-0KO#(6"E4+:BY02QS(DF:G@F1LD4*Z8![J'U&(F'33WTQ'[Q!,!P^T.:
M_3=CLGJ*:74RKGCWM3&!PYU\MKH$1')I@0Z&X\"LDJ.]%AI9[Z:?;<@$^6XM
M<&4$Q[0X&!XN&CFQV<-"-5S1O,YK8)A'^Q;<SU$?_7"RA]OZ/J'ISF_]"96=
M?S/&_P#$)7]:^AWHQMP!_+;SKUHI@/S'@>JSNUGV1IVTF/WF1Z/6LE5.%:V&
M0KGTS*=*D:)85'D8DU77=MHJ2$ZCB-4(\*!%R'.0QP.4>ABB',RRO&:W#KN;
M9<*BDJ)OLAQ-+,$YNL?XQH2/+RU5^QK(*7++9]_24T^FDB:0/=:6.,/$M.H\
MP=EDD3]@O]4/]'*[*UEM/U;#U>KY^?565WJ/Q7ZYR*%Y'=6-68'S<9FW/SQN
MIEO-#-##^=I[!^(M<Z!D1]1&.$:] MBF83<A&-$%SGFI,XCV*J)%]]VV<G7%
M4.TB1%M<&;IY[U*T;\QV*(W,<CG"9\=%]0QYKGF"U.B3]A)7\B2:]4@6TM(J
M+.DIIU09-)11N"AE2)N"F1#^"0A"D77[KXJJ#COQR#Y'ZWN7L$GN7 81B]H#
M;%KYCDG5;L%O>0C2VJT[Z2H8Z(Q<@Z=A$-@%R=91V8H*E.4QF_"+MN<-C\S^
M117PX:D9"RG9==Z9N[A.5S1LK*X_DU*;9\B/*K%*HQ]&B9$.WZ6PN[Z#<.6[
M4H&145?)=4U?933,1=W?X 9>'SR1Z"T34W+>49C#NZ]PL.+,OZY9&O3Z^H,T
M(MNP*RRI" ]*FYCQCW$H"HKF3 Y#LU4_=,BJHF0BQWJCAPSU0_,^N&;EPT<H
M;(98,@Z:+JMG*)P&9 %$7"!TUDC@'P$H@(<(H]W:V S6_P!=/#%I=6V6=Y_%
MN==7,?7S+-7UWF$XC-&<BPE9@V+3&5=L,F*B(F2134=ND#^[[PN2'.DJ*9"B
M1=[\?-6V+UR\AF$H?6[5G=[6K6S)4/8XS8G$6X.0(JPUN291\-)O(F^X\^><
M,)+\3,7[5,I4T45UUEA.D4_M**$(12#HEI)5O,Y6L];J[DY\SD\R>OG3(>/,
M;T'&V3'U)AM;82EO$?PZWC(%L5T"$HD5VFHF"A$4E$4?<."JJIU"D6,VG>2\
MK:E^/'R.*XTR2^F[++^1%'!#?8(KA5PY7CG<>V@[#E%.7]YP891^Q:%$SL%#
M&2<O04*;O*4W-9[(XG9<ISNEE7:49^/LI9U5+I1J^?,D \F=8/F GI $+,>]
M&1U>/8?/GVN<VCJON9-,'N\#. !AYGE$+-#R$>+S#FM^BMKSA1\XY:D<@HQM
M/-<I6TY'>SE7SO\ BB6BDGC%:#5,#8ZR[QT60CNQ5;M*VZJ>Y_,+MW:CO-?,
MJ[E4MGN5MIY>/!M0V5(9):U]%#D&S'.AR/ :.+NNRQGN)VGLMAP+\WIZR:[(
MVAKIDUSW%M6XB)EAI<6B)],!&"G[.M,F=G=H/'AHK>KC>*E@UQI[%Y:O]9I4
MZ[K,G;K' U0S)M&S+YL/N"U9A )ID*8I_:%14Q0 Y@,6GV%U-A>(Y3W'MS)-
M3?&7HT\E[VAX =,)+VM((^H:^>B]R\4TW+LEQ?"*[WI%I%F$^:UKRUT1):.!
M(UB(0UC Q*X3!60<A:)6[RKX!Q[:+7D#'VLF(XO,6#8F\R;BT2E4EIVNB[,Q
M(X6ZJ.(QNI((JKI$*FFK\IW]A3'4$>YD]JLG<*VX/F%RD"GO5YK)M-6F4T,:
M6,G"7S#1H#QC#I\EP6"KNF!UF8V"@J73+3;Z:3.I/<<7N;,=+CQB3$_5Q!_=
MNNK8W\=U+S!H^7>>Y;0YH7V?L>,IO.B>:FN3'S*!J-BCF$A.(USZ:D<J24;$
M.6/R3GM63435*() 0I2I<[U][I56+=QYG:RU6RA9@E'62J-U.^D#IL^6]PEB
M9[A!>3,:0\0.L1U7':NWLB_8%.SFNN$U^5ULO[OWQ,<)<A\H<BSB#Q 8X.:=
M-Q"&BC':]'<7?GQV^/7,T/CG(&R= KMOG);<C 6*+JZQW>\X0];=+UB"D6;N
M+,1X^(92'<+.6[9)55-T[!4B)NG<EA?=W%K;B/<*]X[;@9<F3/ES);#&+&.A
M,#-=06M/&&^FJVOM3D=7D>)6Z^UCQ,=,IYTMS](/(+F"8/\ 6XQ'Q\U&+_<W
M#VN?B$V8D?'%7LX:WWAMLK3<097HN<)B8FKSJ_;LG)L82P3$-)R[I^ZCXOZ1
M BDS4,K[C*055/[:2I"D"AN<7.+CN3%724 )36C8-'[EG]!^+7">EFF^UVP=
M.S#F_,F9;[HYE^)M>2KUE!_9ZY9BV2A+6=]8ZU# 0&\=\W(,4E63@'"ZQ&YO
MYAS&$XPN15 9OV2SK6?%!X:-:: \R\G7-IXBP,<L/,.R16N7LB0=7MI44L54
MNPR:H$:S%J&PJ'$JJH@X%%(A@.GWD.1=TU%H.P6N&]VJ[G4?4K??5W&V0;DU
MI6R-&V]R%#SV-L@X^>J-VTE:8KZB>*<M[9!)KJ.4_9175^;!$K<A>\Z1R+(.
MI:@1WEPVW\J=XV6S#FEHWU6RU(X.UJK-"O<A5Z]C5M!Q=A7C[$E%( =N\>?-
M0Z"RR?:E\TJLN=0XG$@ID4&!OKMC:O#%IE4#9MFZ;><^[<O=-[WLXXD'*5HJ
MN+8&QR+!*4>V452.VLV\ARI-E9 5B.5&31015 YS' BSEV]UBK?A-\>6SN<M
M0+_FV>S3E6,Q;C*PY4R;D!U>'-<":LXQCW(4$Q5:-V-?E"%G'(HJI]_M.%T#
M 8PIE$2*D0N'<X8TQKCC.^L>J/E3QUMRT=4VXH[4Y*R7#R6(<H24P9H_F/Q+
M$2"C2+7IUL0=*&9E.\5!1N8H.A6(8Q@(K/\ RA8;SK8=D\<;.[D:G9NVYTR2
MU7HZ,GCO6W*$M#):\Y<&.:2V5K;)0M7?)N)MJW>'7.@_]TC19J*8F= #?L$B
MN$HN%];]_P#Q&UW!>#[;=D< 9:P<C4,96N[.%9;(%5<5B6,%>4MIWBIUI29I
MEOKQ$7Q!5/\ ,D;' JI@.502+QQQV1?)!X6+\OK+DRWY5POAFP79]91F\81-
M<G:Y=/FT6D6]O>,)RR,DX:==NH^+;>]&.7;5PE[0$631.'<-QQ#(;)8@\7^T
MT-=+<26Q>0[Y^(/6"JV662Z7W@;1=ZV@F,: 8,''0; ^(Z*W&G>0K&]Y:1ZT
M+YNMF_J3U%!16NN-0&OUY@NLF!U&3ADU.Z(NX0,(E,+<ZR8B41*80Z".X8[,
ML&5R/<LF'6:80-OS"#OFTG0]0=EB.1T.18I- O&57ILM^H+:9O$C^Z8:@^!\
M0I"-MS'%$2F\S.V)1^TIM)WO7]8& 6/KRQ_I"H_R19_\0;_O*L_K"4WZ1F-W
MT_[ D_,AL"?/Q6"&=\"^/C92<4M>7]^<NSUP."@'ML;H@_J\\\,H(#[DH\K!
M8<DPH40]#.R+'#J/0WKSIW3!JRX4+J*GP>ST4PC^;)N373'?WC%Q@3O#PV7=
MM'<3[.N%1.RJ]5TIA_ESK<YLL>0(:(CH57+8;!FOQMW:3LWCZW*RA<,83C+W
M+')-<>77&2C843$$4<@8\M[&1J;WVSF_@2;)50Y2C]X4?@.,W+MOEV%4S;[<
M;923K(R>>39DX5!#8QAQEGE #0K:;3W*P_,JMUC;45U/>GR!Q+))IPYT(<@Y
M^FIU!5P>L?D<G<V8C@+AD7RM;/XKR0 JQ]XQ]%ZQ1^0HZNRS<Y@(I&VJOMQ9
MRD3*MNU=N91-%R4IA(H0#%ZCJN*&SYA0FKL^$6B=*8 .7WQEEVGK,LF+([\#
MJW8K*\OE7;#ZUM/<LIODL3#$-]AKPT'^$/ ^J&W(;[^*R1CMPX-E*13YYYD=
MKI%HRDF#QU'&TL=$)(-FKI)=PP.8[!4A"/$2"F)C$.  ;KVC\!]RJPVIKJ>9
M34>#VB1.=*]7YB"6Q'J$7"'70JOR<REV^=*J:W*[S4T[9_H% XF /I<6B#NA
M.Q5X>O?DKU0V9R&PQ+BBU7B7N[R&D9=JVG<87BL,'#2%0(K)*FEI>$:1;=0B
M9NX"&.3O'T)U'H'/SAD?;'*<9M9N5UI::71B9#2:UP&NFH<28?Z6QW6[V+N/
MC5_K&T%MGU;JIVX,HM/G$$#B?(P@K!NO_#]?3^5^\'3]G][X=/U\I7(<>6G&
M'73\>BT3B?3%T>L/J_#K_2J8MF?"=A;.><K7L1BW/&Q.HV2<GI%0S.XUWNPU
M:&RH':!%WT_%'2,5M,/D^H.%D3^TN<15,B*QCJ&E%7QNUXP,->-?Q3>3=QAF
MZY%M4=FZ%Q!,2$?D1_%3#B 6IN18-- &<NRC8]])J2CB<77<JNA.<R@_=Z!U
M#A%(.O?@'P#D7#> )>Y[([93V +%0,992D]3WF45?['%K38*O"V:52(U3:D>
MH0;F9?+*"W3[%BE4$"K@;[W"+H'E U*QAL5Y;O&AJU*KV/'6/'6L686%=>8K
MDR5&PT13'R4Q,TEW3I!%NX3BU*^^@VWM%]LQ/;3[?3X@16;:>>'W#.K69QV2
MNV7\Y;7;!L(9S6ZCD_8:V_BI_0Z^[34;.&E38 G[+)ZLQ74;BY4.L<B*IRI
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MUN\1>*<$T#..';SF_/\ M#A;.-,B*%(XMV$NGXMK51KT.Y?KMR4\C5NP4AI
M0>)]'*/MJ)*-$%$^TR9>A%C32?R]&N4)9ZFUR#L5M9FO &/+ A9*!JYDC)BD
MAB"">,G N8]D]8-FZ#B5B&9Q[00*#;W"?=4,8ICE,19(;9>*V1V7RI/9&J6[
MVU^MT)=:/ XZR!BK#=KCX[&UFJL%&KP@-4:^\;'0AW4G#.#-G2I 5!1, #M
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M)PB<(G"+3H'Z _R<B CRAJH@(0\$[2_NAZ?J#D<&1C 1^"F)V\$Z!^@.?20
MV6O0.-M!LBTZ!Z>@>GP] ]/Z.3$H-! ;+7H'(\O!(!.$3A$X1.$3A$X1.$3A
M$X1.$3A%%.=,Q5#7O#>3<XW\)0:7BBE6"]V8D(P-*3"L178Y>1=H1D>4Z0.G
MRY$>Q(ICID[S )SE* F B\@63_S)NW.R4ZKC?QVZ?2",[*',VC)^;AY;,V0"
M@L(E2>(4VGM$:G"'$#=>K]Q(($^WJ #UD@'?5<PU&I,%$6,? GY'M^LG+Y\W
M\R5!X24M*K5U/*O(RLS^6Y%B7N.DR8T:E(Q=(JGLD4$"?.NA62[NIVYAY\\6
MCP"XCOILO5!HYXN=0/'_  Y0P?CQ)W?WC$&=AS%=CH6/)LX0Q !=N6<4;H(5
M^*6,)A%E&(M&P@/WRG$.[CBV,8"*<G0A$P5AX  ?  #^@ Y 8P; ;QV2)\5K
MR8!0G$!T1.2B<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G"*$MEO\.F>O\ PUDW_LN:X14\?E]?\)CO_JRG^^5Y)V7T?2%?
7B'P'^O\ ZPY"^5^^$3A$X1.$3A%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ MP"X P$1  (1 0,1 ?_$ ,(   $$ @,! 0
M      D !@<(!0H! @0#"P$  00# 0$               4&!P@" P0!"1
M  8! P($! ,$" 0$!P   0(#! 4&!P 1""$2,1,4"4%1(A5A,A9Q@2,*\)&Q
M0E(S)!>A8E,EP=%#)N%R@G,T*!D1  $"!0(#!@('!@,&!@,   $" P 1(00%
M$@8Q00=187$B$P@R%(&1H<%"(Q7PL?%28C/1X19R@I)#)!>BLL)3)3=C- G_
MV@ , P$  A$#$0 _ -_C1!"T00M$$+1!"T00M$$<=Q=A'<-@\=NNW]7QT01A
M9:Q04(4/NTHS9F4W!-NJJ NE_@(-V:?>Z<#U\"$-H@AKDM$S(&_]NU.4<H"(
M>6]F5$X!D9/8=E$B.B'D%$]A#H5$0W^6B".PM,AN>T5IFM0*9M^X&,8[EG"8
M"/TE]3)/&Z!S;C_TP#\-$$=QK,V8!,\R!/=/\STC2$8DZ&V'8HL%S)B)@$.A
MAW^&B"/H%/?"('+>[IVB&X;/8$2"&W3H-<$VW_U;_CH@CYFK,NF(E0OME!;N
M+V@NG".B 7?Z@,3[0B)O#K]0;:((X"/O[43'9V6"ER@4O:A,02S,V^P"01<Q
MCLINX0'Q\L0_#1!'!9ZSQFYIRI.54A$QEG]<?(2Q"@ >/H52,I+RP^ %(H(>
M'71!&8B;7 S*I4&D@F5YVB;[>[(>/DTNW\P'9.P2<&  #J)2B :((<X& =MA
M =_#;KO^\-$$<Z((6B"%H@A:((6B"%H@A:((6B"%H@A:((X$=@$1^']-@_$=
M$$8*7L,9#)D,]54*NL8$V;-!(SA\^4-_Z3)JCW*K&#XCMVD\3"&@T$X(;7IK
M;9!*9=P-/C! 0,S;>0\L3A/K_GO!!5A&B<!\$RK'+_B ?#Q*M0GPC)295%1'
MV-%5:D,)&><>ECFL<T<RDU/R:AW+I%DT047>OGLH\.JY!)%%,3J&[@*4H".P
M!H4H)XP-H+GP\8J)'>Y-Q5DI:KH-+%=_T=<YZ/J]5S&[QE>X["<[8)=4K:&C
M&63Y.%;5PQ9EVH"+1R94K-PL($(L)A !]C&+W&.*HE A1#81 W>&P  AMU\0
M Y#@'00_9H@@-& .9V=;A=N<6$\NR,#'V:L6ODB7B==(.#28?<ZWB9!6-D:I
M+M3BNT?W>@NY",DS;AN\8O 4[>U,VQ!!%.(N19K+7%OC[DJRO?NMEN^'Z'8[
M%(>6BB#^?D:ZP5FG I( 5NB9Q)BJ/84 *7?8-M$$5#Y[<GLHXHM%'J^%)&(8
M.*&UA\Z\B'<A$(S0-\'DO=?HIJHB54!)&2EXD95TJ@ZV%5-O$+G*&P:((* U
M4353*JB?O16(FLD8 V**:I .02] V[B" [?CH@CA9TF@/:<IQ$1*  4NXF[O
MD =1*'S\-^FM+CNC@E2CJ2FDJ:N=94'./0!Q40!WPWI2(@[ 4$I2,;R';L**
MBJ @LB([F**;LIR*H?E\$S%ZAUUZIPI*QI5Y)?[TQ/R^'.//*9:2#/LY1A31
M-FKI/,@GQYY@81 8*?6_UB*?;OVL9P !0Q2]NQ2.2G\0_B!\<VU%Q.J1'<>,
M>+*4&1(C/0]I82BHL3I.8V81(!G,/()@B^2  ZG2+N)':&_@=(3 (=>FL&G?
M4)!2I,CSY^$;7&_3($P01RAS ("&X> _T^'36V-<<Z((6B"%H@A:((6B"%H@
MA:((X$0#QZ?C\/WCX!H@ADO;&\?.5H6NI)*OTC&2D)1P'?%PYA$-DU *(^MD
M3$'<&Y##V^*@@'0?4RG7A&*R4I)'$1]HVM,8A0[_ ,UP_F7)#$<S3\?.>K]_
M4$B!])&C1,P?2DD!2@'SU@%3>T<H]40&2YSE#>I.4*C>)>[P-?DA6FL=V<]3
MM\4\17:/XJ4]&V?-SB@Z*FHO'R#-TFJV<D R+DIA[!Z#KHO;!U"$N<$J3,'D
M83;/)M/%32OC"I1(#V/92K![&2+=)W'R3-RQ?LUR 9%VR?(';NVRZ8_F2<(*
MF*8H^(#I/MM4R%<1"H0>*>$"DXVXY@[SQ5Y1\"<E@5XG@6S9*PDF,J8171Q?
M8F2]YP9;6QU3&,@6+K4PT]$X 0,BO%#V[&3W#JCR+4\#,EV'+7$#C_>;4Y%]
M9W^/HN(GY,0%3[O,55TYJCZ? ^Q?4(3ZT*+HJI=R&*IW 8P#OH@BB$AQ\R):
MFG.-:CP;J(RWBCF-+<@N.\G*,U(^-MTC9<44M:TU%-\H )/ZOD6'^X03\ 'R
MO,6*8_U) .B"+@^VM&7J!X+<<(C)5&L.-;G#41PTGJ#9$03L-85;3LT#2'DD
MR+*@HX3CQ2$@E'82@ _'1!%"K7Q/Y-YMQ3S3SO*94MV';OR.A+TU9X)E\=4N
MVE;8KQA$RU>P_673B1;FL4/.R[1H:16*V> 5)W*"8"]^XB007KC;;'EZP#A:
MWR3)W'2EDQ1CZ9E&,@@LV?LI1]5HT\FR>MW %<).V4@"J2@' ![RCH@B,>8%
MQNM7QJ_3QM,2$?:3/(.6GBU9&/E\A,,8,)=HCD&QT>N/2./NDS#1+@#$ $E
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MQ;[=%%,BQ0*>6 "  </M)@[NWH(;B&G*/:/NM*!JR=C.0XI=G]/EXPD)]T&
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M.,6["'8HQS8/)1:ID332$QE%/'<YU%! 3+*J',)CG'<QS"(CU$=8/#\DJ_"
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M"83:YQE)F\ $^I20"C(3ERK0UCZ7]/\ JKF=HMLV=ZX7;(* ())IW5XQO%8
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M2\6];^@ZDET5*Q\!/]([YSXF).GR%KT]&6-+N*TDUV\%/[% Q2$<F.6%>F*
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M_J*9]T64AF\+!(LH*,1C8ABQ:$:QD2S3:L&K9JD!0(W8,$ 220;HD+L4I"@
M!\-):75O/+];U%WI\[BBE4B3QDHB1F3PF84[?T+1 MFEM"U \HU)U#NE/L[H
M]LW%MIR*D(IR'>WD62[102#]1 6+VD5(8! 2G24$#E$.I1+N'769I0\8[@01
M,<(Q--E'4G7V?KNLLP%:)E_$NTG&&%JNH)1_*5V) 6*7^Z50 T01X+>!7RM>
M@ $1^]3K4[L@E$#&C8<OW9V4^VP^4H=JFD.__6T00[72 G3#H F\T!#N';<
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M&.:F$/H+MW&#Y;ZNXNW8QV.-PF7J@?;'RHQ+N\.ON\'OU%2SM:T69 S(TI-
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M>$(_4_<+6!VBY?MM:G;A.F1.@B=)\#R^N- ,I"E O;L %*!2@ ;!V@'CMO\
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M15R>BA[:<. C+W(-M7%CBTW@(4%O:=/ 41*M(L[P#W__ (G3'R_VCS[N&_\
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MJ=%-Q?Z?ZF8U8.DN+"3WA1E6??*(RZN8,9_:3C)$RR"K]OKC01 X*% _7ZP
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M7-=M,>:IN5;G#;C(U9&0:R<BBA84$_J,V5;EW$0/N!>NM6/]T0MFF497!!+
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M&_E+<-\ D2^J'&1=,XE HB(F#<.@ATWV[@[@#</GMOMK5'5'=0X)E$P@(_(
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M&(F'TI&V\1+MN/4>NE:U]>VF"\ZX@K*Y+((F3,\ (Y+<-6RM3:$?!I (X)%
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M-BG-W=H")1VV,7CV/N$KM%J3?I(4E0F-,N\=_?'#=X]G)@INTI5CRF2DGF?
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M^VEC7_\ #+0A%>(E^Z(L4_EQ,RBJ )<E\=^G$P;F/2K(57LW_,)"R1R ?;X
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M.16*AU=R*NQ3^I&2ETC=#&*;JB@.P)^)MQT00^"E$!'?<?$=QV^.W0  >@
M:(([Z((6B"%H@A:((6B"%MOT'J&B"&=*UM4'"TW!.4XV=\GL.<4S"PDTTP$4
MFLJV3'^,0IA^E8O\=/X"(?3H@AB6" HN2RP=<R=5F#]]6;+#7:$A9WN<Q1;7
M6E_4P4]$K>8FUF5(IV/G(D4*=1(_:8Z8'*&Q!%?UL>WKCY2^<F5:LY;W&[9'
MG+MF;'\/'L70NF;Z-Q=#U^ KKAL0RQI)\C(5WS2^6 ^9YH$ H&Z:(('AQ?Q/
M%W=WQPQ1CGE+4,MU/&UEJ'+'*:3J@*K93B+DI]TD)-BZRM7@2A47MIO<XNF[
MCIH@301R"B(]R0=VB"+(9DS%R94Y)9&H..[[%564KD+0[#@'$$O5H):K\H(8
MZS<^7%"9$EG*;AM8:;WJMSQS!9)VS(DFX,FHFIN7(D >02,>-S"=+WF\*?XP
M3F;?M*W79BPR:PM6$'"/YN1,42J&291,<X?O#%,40\P$4TA'N VYC%Z]!UJ*
M[R=%HE_LS^^,$,,-.%QM)"CWP.[(/,&0P3Q#PMFAS^LLN2>5['CUG&3CO&TF
MB_6K^2[BT,@YL%;IY''V)_'566\MBEO_ *QRB0H;J'[=;DNN2_-D3W"49*7=
M2_*6!7F)_?!(FTY'*UE&TF%\TBC0A9TQ7S)TR?MH_P!%Z\P.XQ=,CQJZ2;_G
M1.0%2' 2B'<&VL2H\I","WJ.I2E%1XUE%5,7\Z^/68+94:M29FV.$,CH2A\8
M726I=CA,>9,>P+0[Z?AJ/<Y%BA$S,U#-45#K-P,0Q@24\OO[#]N!"^(*9^$>
MI;"3,%1\3#&RKS=EZ)9<Q'JV#YO(>+.-CR$9Y\R"PM,9'2E8-*0S&QRZM2IB
MK!X_N2=*KD@D^E0!=H)$1-Y0*F*(#Z-1HH_52,Z\H8O,*RY0EK#C"3J\QR(8
M<=+3C:Q3)[IQ2@&=HO;3)CP\2^Q_)V>/%B_EU*$>!6561(T)Y;AV )N1!,P#
MK MI[Y]]8R"E 5,X;%RD:/F3!M(Y3T[-.<6.0>.\18:'<<AXLQ@R3R@Z5<K0
M$5E*O73!MSA'Y&RB#MBA+.&1&Y73,$?-; <@@0V(;7,'50<HS"T@$2G.'SQ!
M?V#,<)R"Q]>KC8.0_&]^G"0^.<EY'H#"C2USB+9 R!<ATXT6U@ZTUGZW771D
M2,Y$D>@(F<J) 8YD0-K=&N+=42L0N$L>TK%$3.6:YGJ$,C U[]0/AF[8^C60
M&)%HS#\ 2.=O&L2IH X<@ BDD43&,8-]$$/J,KCMZX;S%C626<H@!XZ(:CW1
M<3W%#8P"8!%\_ .@KG_+X$ -MQ((>X%V_K$1ZB(CU^D-Q'?8 ^&B".VB"%H@
MA:((6B"%H@A:((6B".#% Y1*8-RCT$.H;A\NFB",5*PL5,-?22;)%TW 0,4I
MP$ADC!^51)9(2+(*$^!B&*8/GH@AFJQMJ@@ L:8MKAR!L$=).TV<XT)W%$",
MI4"^G>@EL E*N"9P_P"H(Z((\\#(T:+669,89C2I*0>^O>1JL.UKCB2D!V\Q
MRJLBD@WE'2HAU5!14Y_V#H@BEE-X,V6 N6)F$SF%*Q82PAEBUYJQA4U*8FWR
M2VM=E&RJIQ%CR9]X=#)52(7MCLX$09M7#T@I)+J'33 !((L7S#8723XPYRA,
M;PTE/W>S8]GZO7HF( IY!Q(6AN2 \Q#S#E(0C1L_454'?H0@B'71!%:.7D4Q
MQIA;B7!.T'K.BT/D+QI8W.381<K*)0%7I+@QSR<DA%-)!PUC4)2,0*HL*(I%
M,<O<8 '?1!!''A$)6&=)]Q56TE&+D[P 0(H@\:F*!@ W4"G34^.B"-?SCS?H
M+*6#?;QPC086P$RUA+D:UE+1%A4YIDQI]#QC.Y(A+5<I"=6BDH$D%/Q2A$$5
M$UA,Z<._** CW:((NCEJ@YJQ=E'DV[QGAQ]F?&_+NBQ2+N-B;# PBE"S"RJ#
MC'KYY:T[*_;D/1;=63,%7#MD5PLW79G**(]Y3 01-<=QAL[GC7@#%I\MW#'6
M2<)5_')6&0Z(Y0<;V*HUI*"?-I:!E_.A[35WZ*BJ)VCQ,Q52 10! P ($$/K
M$&/*5QZ@IROEM]@R#<KM;I?(-YL$J1I)6RY7.=]*@]EE(B":(QL6S219(MT&
MR*22*"29=Q$0$PD$2XD2VSPD B2--BQZ&*!R/K&H@;<1(4"!]OA14[NG:9P<
M/^0>FB"'+$5R*ADCD9MA(HH81<.UE#N'[T0'\[QZJ)EUQ$W7M$>T/@&VB",\
M  4  / -$$<Z((6B"%H@A:((6B"%H@A:((6B"%H@CCIN&^V_P^?AUV_=H@A#
MML.^VWQW\/W[Z((Q$V$"9DH6Q?:0CQ 0/]X%H5IU#;J9X() /X[@.B"&>WJD
M2L4KBH663B"BFD) AI5*3BQ2+U3[63\7[0J AX GVE'X:((^Y6F16(=J4Q69
MS\PE&3BW<6Y_,.Q3+1SIPU$VWQ!$O[-$$=U)6[()*?<*G"NTP ?/]!8T_+$N
MP;=Q9:/8$#?X[FVV^.B"/H6?MXIAVT!R7<H=O_N. $ W#H/TN!#8/P'PT01!
MV H:#I./8ZO8<CX:P4TLY>I1K+*Y&@+24KZ9N<U+V".0EZ^E(H+M(^SOG2 I
M@?=J=+R3AW$$ ((F0$L@O>XBCNI02 @ IG:M7TVY)N ^8 *.CQ[0QP)\TS!M
MH@CEQ5$S$,K:;5-RB0"8_EK/6T%& 4J>YR&2C"L2F2,7Q QS!\]$$9ZM)U%)
ML8E8& %$!*"WV=5@L * 0H "ZC0YQ.J!0#<3")A\=$$.8.SMZ=O9^&W;M_9H
3@CMH@A:((6B"%H@A:((6B"/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
